Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by foofadoooon Dec 24, 2019 9:17am
144 Views
Post# 30487112

RE:Not pumping, don't hate me

RE:Not pumping, don't hate me

I played with that thought last night.......Dec 19, 2017 Equivalencies (pre reverse ). Imagine 20,000 shares owned and you fully excercised your rights = 400,000 shares divided by 1000= 400 shares.

About 950,000,000 (million) shares outstanding pre reverse and 23,000,000 (million) after the reverse.  

IF you paid $3.60 per share(I believe was close worst case scenario) Your cost = $72,000....excercising all your rights cost approximately $6,000....Total cost to you...$78,000.


working with the word EQIVALENT....and a news release from Dec 18, 2017. Equivalent cost today with fewer outstanding shares would be about $1360 per share.....400x1360=$544,000. 544,000-78,000...= a net profit of $466,000 divided by the number of years you have owned the shares.

Those that put the bulk their shares in a (Canadian) TFSA probably we're unable to excercising all their rights due to investment on the TFSA. HOWEVER ...due to price fluctuations since the roll back you could have actually bought cheaper than those who exercised their rights! GLTA in the future and MERRY CHRISTMAS!!

foof.      https://stockhouse.com/news/press-releases/2017/12/18/prometic-s-plasminogen-ryplazim-granted-orphan-drug-designation-for-the
 

<< Previous
Bullboard Posts
Next >>